抗抑郁药的使用和肝细胞癌患者的死亡率
Kuan-Lun Huang1,2, Yi-Lung Chen2,3, Robert Stewart4,5
1Tsaotun Psychiatric Center, Ministry of Health and Welfare, Nantou, Taiwan.
JAMA network open
|September 6, 2023
概括
在肝细胞癌 (HCC) 诊断后使用抗抑郁药与降低死亡率有关. 这一发现表明了潜在的益处,需要在肝癌患者的临床试验中进一步调查.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
- 抗抑郁药已经显示出对癌细胞的潜在亡作用,但它们对HCC预后的影响尚未被探索.
研究的目的:
- 为了调查抗抑郁药的使用和诊断为HCC的患者的死亡风险之间的联系.
- 为了确定抗抑郁药的使用时间 (诊断前或后) 是否影响HCC患者的结果.
主要方法:
- 一项基于人口的队列研究,利用台湾国家健康保险研究数据库.
- 包括1999年至2017年期间新诊断出HCC的308,938名患者.
- 考克斯比例危险回归分析,以评估与抗抑郁药物使用相关的死亡风险.
主要成果:
- 在HCC诊断之前使用抗抑郁药物与整体或癌症特异性死亡率没有显著关联.
- 在HCC诊断后使用抗抑郁药与显著降低整体死亡率 (aHR,0.69) 和癌症特异性死亡率 (aHR,0.63) 相关.
- 这些关联在各种抗抑郁药类和并发症中保持一致.
结论:
- 诊断后使用抗抑郁药可能与肝细胞癌患者的死亡率降低有关.
- 建议进行进一步的研究,包括随机临床试验,以确认这些发现并探索治疗潜力.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.3K
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
93
相关概念视频
Antidepressant Drugs: Overview
557
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
557
Antidepressant Drugs: MAOIs and Other Agents
270
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
270
Hazard Ratio
155
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
155
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
195
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
195
Electroconvulsive Therapy
68
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
68
Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
